A Propensity Score-Weighted Comparison of Vedolizumab, Adalimumab, and Golimumab in Patients with Ulcerative Colitis: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)
Fabio Salvatore Macaluso 1
Marco Ventimiglia 1
Walter Fries 2
Maria Cappello 3
Barbara Scrivo 4
Antonio Magnano
Dario Pluchino
Salvatore Camilleri
Serena Garufi
Roberto Di Mitri
Filippo Mocciaro
Giovanni Magri
Concetta Ferracane
Michele Citrano
Francesco Graziano
Carmelo Bertolami
Sara Renna
Rosalba Orlando
Giulia
1 'Villa Sofia-Cervello' Hospital,Palermo (Pa),Italy
2 Inflammatory Bowel Disease Unit, A.O.U. Policlinico 'G. Martino”,Messina,Italy
3 UOC Gastroenterologia ed Epatologia Di.Bi.Mis - University of Palermo,Palermo,Italy
4 UOC Gastroenterologia ed Epatologia Di.Bi.Mis - University of Palerm
Session
IBD II (Posters)
Conference
UEG Week 2019
Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]